Neumora Therapeutics Ratios (2022-2026) | NMRA

Ratios Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter) 520.47M473.20M427.34M378.50M334.75M286.86M240.29M200.83M184.44M172.46M
Equity Average (Quarter) -434.43M-462.38M-495.73M-0.42M490.88M446.81M402.90M351.00M303.90M257.71M205.62M157.52M118.02M87.28M
Invested Capital (Quarter) -422.00M-446.85M-477.92M-513.54M512.69M469.08M424.54M381.26M320.74M287.06M228.36M182.88M132.16M158.40M123.64M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -77.24-28.72-28.51
Debt to Equity (Quarter) 0.110.150.520.75
Debt Ratio (Quarter) 0.090.110.290.34
Equity Ratio (Quarter) -1.050.940.950.940.940.910.910.890.820.740.540.46
Times Interest Earned (Quarter) -77.24-28.72-28.51
Valuation
Enterprise Value (Quarter) -252.51M-371.88M-210.87M-204.22M-509.56M-453.98M-422.71M-371.64M-276.93M-307.58M-128.07M-124.52M-129.07M-182.53M-147.07M
Return Ratios
Return on Capital Employed (Quarter) -50.89%-60.86%-72.92%-90.71%-86.42%-106.13%-120.72%-140.35%-158.67%-156.72%
Return on Invested Capital (Quarter) -0.01%-0.01%-0.02%-0.02%-0.02%
Return on Assets (Quarter) 0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%
Return on Equity (Quarter) 0.00%3.67%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.02%-0.02%-0.03%